Morgan Stanley’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21.9M Buy
693,752
+43,914
+7% +$1.38M ﹤0.01% 2706
2025
Q1
$21.3M Sell
649,838
-27,829
-4% -$911K ﹤0.01% 2634
2024
Q4
$24.5M Sell
677,667
-48,446
-7% -$1.75M ﹤0.01% 2567
2024
Q3
$22.6M Buy
726,113
+55,546
+8% +$1.73M ﹤0.01% 2681
2024
Q2
$17.9M Buy
670,567
+20,341
+3% +$544K ﹤0.01% 2783
2024
Q1
$22.2M Sell
650,226
-796,484
-55% -$27.2M ﹤0.01% 2585
2023
Q4
$41.9M Buy
1,446,710
+918,131
+174% +$26.6M ﹤0.01% 2643
2023
Q3
$14.6M Sell
528,579
-27,319
-5% -$753K ﹤0.01% 2772
2023
Q2
$16.7M Buy
555,898
+15,013
+3% +$451K ﹤0.01% 2651
2023
Q1
$19.6M Sell
540,885
-189,558
-26% -$6.87M ﹤0.01% 2452
2022
Q4
$26.1M Buy
730,443
+214,709
+42% +$7.66M ﹤0.01% 2078
2022
Q3
$17.5M Buy
515,734
+41,705
+9% +$1.41M ﹤0.01% 2348
2022
Q2
$13.7M Buy
474,029
+241,325
+104% +$6.98M ﹤0.01% 2715
2022
Q1
$7.52M Sell
232,704
-45,348
-16% -$1.47M ﹤0.01% 3242
2021
Q4
$8.11M Buy
278,052
+53,295
+24% +$1.55M ﹤0.01% 3169
2021
Q3
$6M Sell
224,757
-38,372
-15% -$1.02M ﹤0.01% 3479
2021
Q2
$8.1M Buy
263,129
+68,458
+35% +$2.11M ﹤0.01% 3241
2021
Q1
$5.1M Sell
194,671
-33,890
-15% -$887K ﹤0.01% 3392
2020
Q4
$5.75M Sell
228,561
-175,476
-43% -$4.42M ﹤0.01% 3101
2020
Q3
$8.42M Sell
404,037
-215,789
-35% -$4.5M ﹤0.01% 2181
2020
Q2
$14.7M Sell
619,826
-522,283
-46% -$12.4M ﹤0.01% 1638
2020
Q1
$20.5M Buy
1,142,109
+67,945
+6% +$1.22M 0.01% 1255
2019
Q4
$25.5M Buy
1,074,164
+728,785
+211% +$17.3M 0.01% 1448
2019
Q3
$9.49M Buy
345,379
+24,106
+8% +$663K ﹤0.01% 2185
2019
Q2
$10.6M Sell
321,273
-67,875
-17% -$2.25M ﹤0.01% 2092
2019
Q1
$13.6M Sell
389,148
-150,051
-28% -$5.26M ﹤0.01% 1742
2018
Q4
$17.9M Buy
539,199
+151,411
+39% +$5.03M 0.01% 1558
2018
Q3
$19.5M Sell
387,788
-89,009
-19% -$4.48M ﹤0.01% 1719
2018
Q2
$28.5M Buy
476,797
+263,559
+124% +$15.8M 0.01% 1307
2018
Q1
$9.77M Sell
213,238
-13,508
-6% -$619K ﹤0.01% 2365
2017
Q4
$9.04M Buy
226,746
+8,400
+4% +$335K ﹤0.01% 2499
2017
Q3
$8.73M Sell
218,346
-192,380
-47% -$7.69M ﹤0.01% 2414
2017
Q2
$17.7M Buy
410,726
+61,451
+18% +$2.65M 0.01% 1641
2017
Q1
$10.9M Sell
349,275
-160,556
-31% -$5.03M ﹤0.01% 2103
2016
Q4
$12.9M Buy
509,831
+176,890
+53% +$4.47M ﹤0.01% 1987
2016
Q3
$8.23M Sell
332,941
-211,519
-39% -$5.23M ﹤0.01% 2186
2016
Q2
$11.1M Sell
544,460
-20,024
-4% -$408K ﹤0.01% 1903
2016
Q1
$8.61M Sell
564,484
-11,610
-2% -$177K ﹤0.01% 1990
2015
Q4
$7.74M Buy
576,094
+138,608
+32% +$1.86M ﹤0.01% 2234
2015
Q3
$6.14M Buy
437,486
+56,190
+15% +$788K ﹤0.01% 2462
2015
Q2
$6.47M Buy
381,296
+343,265
+903% +$5.83M ﹤0.01% 2563
2015
Q1
$460K Sell
38,031
-151,534
-80% -$1.83M ﹤0.01% 4713
2014
Q4
$1.57M Buy
189,565
+134,992
+247% +$1.12M ﹤0.01% 3755
2014
Q3
$475K Sell
54,573
-19,401
-26% -$169K ﹤0.01% 4605
2014
Q2
$810K Sell
73,974
-231,903
-76% -$2.54M ﹤0.01% 4224
2014
Q1
$2.74M Buy
305,877
+158,962
+108% +$1.42M ﹤0.01% 3153
2013
Q4
$1.11M Buy
146,915
+87,541
+147% +$660K ﹤0.01% 3858
2013
Q3
$435K Sell
59,374
-4,339
-7% -$31.8K ﹤0.01% 4427
2013
Q2
$410K Buy
+63,713
New +$410K ﹤0.01% 4397